Recorded Course: New Drug Update Part 1 is organized by University Learning Systems (ULS).

Released: 2022-04-27
Expires: 2025-04-27

Learning Objectives:
1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
2. Discuss the new drugs with respect to their pharmacology, pharmacokinet- ics, approved and unapproved indications.
3. Describe their adverse effects and drug interaction that may affect patient compliance.
4. Compare efficacy, dosage and cost to existing agents.
5. Discuss the patient oriented outcomes or evi- dence that may or may not exist for each of the new medications and when they may or may not be appropriate to rec- ommend for selected patients.
6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.


PhysicianNursingPharmacistPhysician Assistant


Pharmacy and MedicineClinical Pharmacology


Obesity in America: Management and Treatment in Children, Adolescents, and Adults
Oct 06, 2022 - Jun 02, 2025 | Text-Based CME
9 Contact Hours
More actions
Diabetes Type 1: Current Approaches in Patient Management for Individuals Diagnosed with Type 1 Diabetes
Oct 06, 2022 - Jun 02, 2025 | Text-Based CME
Endocrinology, Metabolism and Diabetes
2.5 Contact Hours
More actions
COVID-19 and Seasonal Flu 2022-2023: What Healthcare Professionals Need to Know
Oct 06, 2022 - Oct 02, 2023 | Text-Based CME
Infectious Disease
2 Contact Hours
More actions